TD Waterhouse Canada’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290K	Sell	1,708 -21,972	-93%	-$3.76M	﹤0.01%	954
2025 Q4	$4M	Buy	23,680 +22,182	+1,481%	+$3.6M	0.02%	327
2025 Q3	$223K	Sell	1,498 -553	-27%	-$75.5K	﹤0.01%	857
2025 Q2	$262K	Sell	2,051 -600	-23%	-$73.7K	﹤0.01%	774
2025 Q1	$329K	Sell	2,651 -3,164	-54%	-$429K	﹤0.01%	718
2024 Q4	$769K	Sell	5,815 -6,553	-53%	-$921K	0.01%	552
2024 Q3	$1.79M	Buy	12,368 +486	+4%	+$70.3K	0.01%	408
2024 Q2	$1.63M	Buy	11,882 +7,244	+156%	+$967K	0.01%	407
2024 Q1	$650K	Buy	4,638 +2,384	+106%	+$326K	﹤0.01%	568
2023 Q4	$338K	Sell	2,254 -707	-24%	-$86.3K	﹤0.01%	598
2023 Q3	$387K	Buy	2,961 +830	+39%	+$106K	﹤0.01%	554
2023 Q2	$279K	Sell	2,131 -119	-5%	-$15.5K	﹤0.01%	618
2023 Q1	$305K	Sell	2,250 -658	-23%	-$86.1K	﹤0.01%	598
2022 Q4	$391K	Buy	2,908 +463	+19%	+$59.8K	﹤0.01%	560
2022 Q3	$303K	Sell	2,445 -12,391	-84%	-$1.54M	﹤0.01%	594
2022 Q2	$2.09M	Buy	14,836 +13,124	+767%	+$1.56M	0.02%	311
2022 Q1	$245K	Buy	1,712 +36	+2%	+$4.69K	﹤0.01%	689
2021 Q4	$267K	Buy	+1,676	New	+$259K	﹤0.01%	710